---
title: "Oragenics (OGEN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/OGEN.US/norm.md"
symbol: "OGEN.US"
name: "Oragenics"
parent: "https://longbridge.com/en/quote/OGEN.US.md"
datetime: "2026-05-20T12:24:38.331Z"
locales:
  - [en](https://longbridge.com/en/quote/OGEN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OGEN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OGEN.US/norm.md)
---

# Oragenics (OGEN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5118 | -0.5401 | -1.96 | -3.10 | -3.65 |
| ROE | -121.76% | -101.01% | -318.45% | 913.37% | 23904.18% |
| Revenue | - | - | - | - | - |
| Net income | -2.20M | -2.29M | -3.07M | -2.27M | -2.22M |
| Operating income | -2.26M | -2.50M | -3.12M | -1.71M | -2.03M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 7.49M | 10.07M | 12.71M | 2.14M | 3.87M |
| Leverage | 1.21 | 1.22 | 1.29 | -1.01 | 28.10 |
| BVPS | 1.41 | 1.94 | 2.38 | -2.59 | 0.1924 |
| Turnover | - | - | - | - | - |
| Cash & STI | 6.11M | 8.40M | 11.40M | 1.97M | 3.42M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -6.05M | -8.17M | -11.01M | 1.03M | -866693.00 |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.20M | -2.84M | -2.98M | -1.31M | -2.11M |
| Investing CF | 4.00M | - | - | - | - |
| Financing CF | -92004.00 | -168628.00 | 12.41M | -132963.00 | 4.67M |
| Free CF | -1.43M | -2.11M | -1.88M | -698921.00 | -1.35M |
| OCF coverage | -1285.32% | - | -99.48% | -988.52% | -1079.99% |
| Repaid & issued | - | -167488.00 | 394836.00 | 0.0000 | 2.23M |
| CapEx | - | - | - | - | - |